磁共振引导心电成像揭示亚临床与显性肥厚型心肌病的电生理特征
该前瞻性多中心研究纳入70例基因阳性但无左室肥厚的亚临床HCM、104例显性HCM(51例基因阳性/53例基因阴性)及37例健康志愿者,利用CMR引导的心电成像(ECGI)标测心外膜电生理。亚临床HCM已显示平均激动时间延长和复极空间异质性增加,且与基因状态及结构改变相关;支持向量机可区分亚临床HCM与健康志愿者(准确率80%)并识别猝死高风险患者(准确率82%)。
要点
- 亚临床HCM(基因阳性无左室肥厚)已存在ECGI可检测的早期电生理异常。
- 显性HCM中电生理基质与基因状态和结构表型(壁厚度、瘢痕)相关。
- 支持向量机模型可辅助区分亚临床HCM和识别猝死高风险患者。
核心结论
- 在无左室肥厚或12导联心电图异常时,HCM肌节基因突变携带者已表现出ECGI检测到的异常电生理表型。
- 显性HCM中电生理异常更严重,且与不良结构改变和基因阳性状态相关。
研究设计与样本
- 前瞻性211人多中心CMR-ECGI研究,包括70例G+LVH-、104例LVH+(51例G+/53例G-)和37例健康志愿者。
- 每例受试者从1000个心外膜位点提取局部激动时间、校正复极时间、校正激活-恢复间期、空间梯度及信号碎裂。
- 最大室壁厚度和瘢痕负荷由CMR得出,并构建支持向量机区分G+LVH-与健康志愿者及低危与中/高危HCM。
主要发现
- 与健康志愿者相比,亚临床HCM显示平均激动时间延长(P=0.008),即使12导联心电图正常(P=0.009),且复极空间异质性更大(GRTc:P=0.005)(23%心电图正常)。
- 显性HCM较亚临床HCM校正激活-恢复间期延长(P<0.001)。
- 平均激动时间与最大室壁厚度相关;空间传导异质性(GAT)和碎裂与瘢痕相关(均P<0.05);G+LVH+较G-LVH+碎裂更多(P=0.002)。
- 支持向量机区分亚临床HCM与健康志愿者(10折交叉验证准确率80%[95%CI:73%-85%]),识别猝死高风险患者(准确率82%[95%CI:78%-86%])。
临床怎么用
- 对于基因阳性但无左室肥厚的HCM携带者,可考虑ECGI检测早期电生理异常。
- 在显性HCM中,ECGI参数(如碎裂、传导异质性)可结合基因状态和结构改变评估心律失常风险。
- 支持向量机模型可能辅助区分亚临床HCM和识别猝死高风险患者,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventricular arrhythmia in hypertrophic cardiomyopathy (HCM) relates to adverse structural change and genetic status. Cardiovascular magnetic resonance (CMR)-guided electrocardiographic imaging (ECGI) noninvasively maps cardiac structural and electrophysiological (EP) properties. OBJECTIVES: The purpose of this study was to establish whether in subclinical HCM (genotype [G]+ left ventricular hypertrophy [LVH]-), ECGI detects early EP abnormality, and in overt HCM, whether the EP substrate relates to genetic status (G+/G-LVH+) and structural phenotype. METHODS: This was a prospective 211-participant CMR-ECGI multicenter study of 70 G+LVH-, 104 LVH+ (51 G+/53 G-), and 37 healthy volunteers (HVs). Local activation time (AT), corrected repolarization time, corrected activation-recovery interval, spatial gradients (GAT/GRTc), and signal fractionation were derived from 1,000 epicardial sites per participant. Maximal wall thickness and scar burden were derived from CMR. A support vector machine was built to discriminate G+LVH- from HV and low-risk HCM from those with intermediate/high-risk score or nonsustained ventricular tachycardia. RESULTS: Compared with HV, subclinical HCM showed mean AT prolongation (P = 0.008) even with normal 12-lead electrocardiograms (ECGs) (P = 0.009), and repolarization was more spatially heterogenous (GRTc: P = 0.005) (23% had normal ECGs). Corrected activation-recovery interval was prolonged in overt vs subclinical HCM (P < 0.001). Mean AT was associated with maximal wall thickness; spatial conduction heterogeneity (GAT) and fractionation were associated with scar (all P < 0.05), and G+LVH+ had more fractionation than G-LVH+ (P = 0.002). The support vector machine discriminated subclinical HCM from HV (10-fold cross-validation accuracy 80% [95% CI: 73%-85%]) and identified patients at higher risk of sudden cardiac death (accuracy 82% [95% CI: 78%-86%]). CONCLUSIONS: In the absence of LVH or 12-lead ECG abnormalities, HCM sarcomere gene mutation carriers express an aberrant EP phenotype detected by ECGI. In overt HCM, abnormalities occur more severely with adverse structural change and positive genetic status.
引用
- Joy G, Lopes LR, Webber M, et al. Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography. J Am Coll Cardiol. 2024. PMID: 38385929. doi:10.1016/j.jacc.2024.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。